Patent · US Expired

JAK-3 inhibitors for treating allergic disorders

US6326373A · kind A · utility

27Cited by
10References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2000
Grant dateDec 4, 2001
Priority date
Expiry dateOct 16, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.